16 days ago
MCK
AnalystsDavid ToungDavid Toung's Stock Forecasts
AnalystsDavid Toung
Analyst Ranking
Top 19%
#855 out of 4565 analysts
Average Return
+4.87%
Win Rate
64%41 out of 64
Risk vs Reward
Poor
Good
David Toung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mckesson CorpMCK | +56.21% | $196.53 | $307.00 | 2021-03-29 - 2022-03-29 | Strong Buy |
Thermo Fisher Scientific IncTMO | +41.32% | $323.15 | $456.66 | 2020-02-23 - 2021-02-24 | Strong Buy |
Unitedhealth Group IncUNH | +36.91% | $398.81 | $546.01 | 2021-04-20 - 2022-04-20 | Strong Buy |
Cencora IncCOR | +35.66% | $141.49 | $191.94 | 2022-07-19 - 2023-07-19 | Strong Buy |
Johnson & JohnsonJNJ | +33.92% | $123.16 | $164.93 | 2020-03-26 - 2021-03-26 | Strong Buy |
David Toung Analyst Color
Get additional color on David Toung's coverage of popular stocks
a month ago
CRL
7 months ago
MCK
8 months ago
LLY
10 months ago
MCK
a year ago
SYK
a year ago
HCA
a year ago
SYK
a year ago
HCA
a year ago
ISRG
2 years ago
MCK
2 years ago
UNH
David Toung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mckesson CorpMCK | 5 | Strong Buy | $570.00 | +5.57% | Maintains | 16 days ago |
Ge Healthcare Technologies IncGEHC | 1 | Strong Buy | $110.00 | +27.98% | Maintains | 25 days ago |
Charles River Laboratories International IncCRL | 2 | Strong Buy | $290.00 | +27.30% | Maintains | a month ago |
Humana IncHUM | 3 | Strong Buy | $550.00 | +76.62% | Upgrades | 4 months ago |
Thermo Fisher Scientific IncTMO | 5 | Strong Buy | $550.00 | -3.80% | Maintains | 6 months ago |
Amgen IncAMGN | 6 | Strong Buy | $310.00 | +15.08% | Maintains | 6 months ago |
Eli Lilly & CoLLY | 2 | Strong Buy | $620.00 | -14.47% | Maintains | 8 months ago |
Catalent IncCTLT | 2 | Strong Buy | $62.00 | +11.11% | Upgrades | 8 months ago |
Stryker CorpSYK | 2 | Strong Buy | $310.00 | -8.05% | Maintains | a year ago |
Silk Road Medical IncSILK | 3 | Strong Buy | $55.00 | +211.61% | Maintains | a year ago |
Hca Healthcare IncHCA | 2 | Strong Buy | $310.00 | -1.31% | Maintains | a year ago |
Cencora IncCOR | 4 | Strong Buy | $190.00 | N/A | Maintains | a year ago |
Intuitive Surgical IncISRG | 2 | Strong Buy | $320.00 | N/A | Maintains | a year ago |
Abbott LaboratoriesABT | 3 | Strong Buy | $135.00 | N/A | Maintains | 2 years ago |
Unitedhealth Group IncUNH | 3 | Strong Buy | $650.00 | N/A | Maintains | 2 years ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $75.00 | N/A | Upgrades | 2 years ago |
Zimmer Biomet Holdings IncZBH | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Merck & Co IncMRK | 3 | Strong Buy | $110.00 | N/A | Upgrades | 2 years ago |
Medtronic PLCMDT | 4 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Teladoc Health IncTDOC | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Bio Techne CorpTECH | 3 | Strong Buy | $122.50 | N/A | Maintains | 3 years ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Abbvie IncABBV | 4 | Strong Buy | $115.00 | N/A | Upgrades | 4 years ago |
Johnson & JohnsonJNJ | 2 | Strong Buy | $155.00 | N/A | Reiterates | 4 years ago |
Wellcare Health Plans IncWCG | 1 | Strong Buy | $360.00 | N/A | Maintains | 6 years ago |
Cardinal Health IncCAH | 3 | Strong Buy | $75.00 | N/A | Maintains | 6 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Allergan PLCAGN | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Aetna IncAET | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.